Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas

Author： Broll R.   Stark A.   Windhovel U.   Best R.   Strik M.W.   Schimmelpenning H.   Schwandner O.   Kujath P.   Bruch H.-P.   Duchrow M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.7, 1999-07, pp. : 1083-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of p53 Mutational Status with mRNA and Protein Expression in a Panel of 24 Human Breast Carcinoma Cell Lines

By Concin N.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 1, 2003-05 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite

Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wildtype p53 breast cancer cells

By              

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1935-1942

Spandidos Publications

Access to resources Recommend Favorite

Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas

By Hasegawa K.   Ichikawa W.   Fujita T.   Ohno R.   Okusa T.   Yoshinaga K.   Sugihara K.  

European Journal of Cancer, Vol. 37, Iss. 12, 2001-08 ,pp. : 1469-1474

Elsevier

Access to resources Recommend Favorite

Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical Carcinomas

By Skomedal H.   Kristensen G.B.   Lie A.K.   Holm R.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

By Liu Caigang   Zhang Hao   Shuang Chen   Lu Yang   Jin Feng   Xu Huimian   Lu Ping  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 747-752

Humana Press, Inc

Access to resources Recommend Favorite